SCHEMBL2199870

SCHEMBL2199870

Cc1ccc(C(=O)NCCO[Si](C)(C)C(C)(C)C)cc1C(=O)c1ccc(N)cc1Cl

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EPHX2 P34913 1/20 0.40
NR1H4 Q96RI1 1/20 0.40
HPGD P15428 1/20 0.40
MEN1 O00255 2/20 0.38
KMT2A Q03164 2/20 0.38
KDM4E B2RXH2 1/20 0.38
MAPK1 P28482 1/20 0.38
MAPK14 Q16539 4/20 0.36
KIT P10721 4/20 0.36
LCK P06239 1/20 0.36
SRC P12931 1/20 0.36
SMN1; SMN2 Q16637 3/20 0.36
TP53 P04637 2/20 0.36
BTK Q06187 1/20 0.36
LMNA P02545 1/20 0.35
MAPT P10636 1/20 0.35
JAK2 O60674 1/20 0.34
TYK2 P29597 1/20 0.34
CA12 O43570 1/20 0.34
CA1 P00915 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2195108 0.86 HPGD (0.55) EPHX2NR1H4HPGDMEN1KMT2A
SCHEMBL2196637 0.82 HPGD (0.51) EPHX2NR1H4HPGDMEN1KMT2A
SCHEMBL21060525 0.78 ESRRG (0.52) EPHX2HPGDKMT2AKDM4EMAPK1
SCHEMBL2197728 0.75 GAA (0.55) EPHX2NR1H4MEN1KMT2AMAPK1
SCHEMBL2201614 0.74 CYP2C9 (0.56) MEN1KMT2AMAPK14SMN1; SMN2LMNA
SCHEMBL2197311 0.73 MAPT (0.49) NR1H4HPGDKDM4EMAPK1MAPK14
SCHEMBL2197758 0.73 KDM4E (0.67) HPGDMEN1KMT2AKDM4ELMNA
SCHEMBL2196873 0.72 KMT2A (0.55) HPGDMEN1KMT2AKDM4ESMN1; SMN2
SCHEMBL2199852 0.72 CYP1A2 (0.54) KMT2ASMN1; SMN2LMNAMAPT
SCHEMBL2198191 0.72 SRD5A2 (0.47) HPGDKDM4EMAPK14SMN1; SMN2LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7977387-B2 Aminobenzophenone compounds LEO PHARMA A/S (DK) 2011-07-12 US disclosed
US-20060166990-A1 Novel aminobenzophenone compounds LEO PHARMA A/S (DK) 2006-07-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060166990-A1 Novel aminobenzophenone compounds NFKBIA, UACA, ALDH7A1 EPHX2 3726/4885NR1H4 629/4885HPGD 1490/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.